KBC Group
PRCT icon

KBC Group’s Procept Biorobotics PRCT Stock Holding History

KBC Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39K Hold
1,713
– – ﹤0.01% 1781
2026
Q1 		$43K Hold
1,713
– – ﹤0.01% 1708
2025
Q4 		$54K Hold
1,713
– – ﹤0.01% 1615
2025
Q3 		$61K Hold
1,713
– – ﹤0.01% 1567
2025
Q2 		$99K Sell
1,713
-523
-23% -$29.6K ﹤0.01% 1211
2025
Q1 		$130K Hold
2,236
– – ﹤0.01% 1334
2024
Q4 		$180K Buy
2,236
+705
+46% +$60.2K ﹤0.01% 1190
2024
Q3 		$123K Buy
1,531
+376
+33% +$26.7K ﹤0.01% 1156
2024
Q2 		$71K Hold
1,155
– – ﹤0.01% 1405
2024
Q1 		$57K Buy
+1,155
New +$55K ﹤0.01% 1473

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KBC Group's PRCT Position: Q2 2026 in Review

KBC Group held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 1,713 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

KBC Group first reported a position in PRCT in Q1 2024 and has held it in 10 quarters since. The position peaked at $180K in Q4 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • KBC Group held 1,713 shares of Procept Biorobotics worth $39K as of Q2 2026.
  • KBC Group left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1781 holding.
  • KBC Group first reported a position in Procept Biorobotics in Q1 2024 and has held it in 10 quarters since.
  • KBC Group's Procept Biorobotics position peaked at $180K in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.